Laura is a Senior Business Manager within the Partnerships Team, providing IP management and technology transfer support to the Medical Research Council (MRC), part of UKRI. She also manages projects funded through the Philanthropic Fund as part of LifeArc’s Rare Disease Translational Challenge and provides IP advice and support to LifeArc’s charity partners.
For the MRC, Laura is the lead point-of-contact responsible for supporting researchers in the MRC Laboratory of Molecular Biology’s Protein and Nucleic Acid Chemistry (PNAC) and Structural Studies Divisions, including scientists within the associated scientific facilities, and Emeritus and Past Group Leaders.
As part of the Rare Disease Translational Challenge, Laura manages projects funded through the Muscular Dystrophy Translational Research Fund, a joint fund created by LifeArc and Muscular Dystrophy UK to accelerate new treatments for people living with the disease.
Laura has an undergraduate degree in Biomedical Science with Intercalated Year from the University of Warwick, during which she spent a year at MRC Technology (now LifeArc), using cell-based assays to screen novel compounds for cancer indications. She subsequently completed a PhD in Cancer Imaging at King’s College London and Bart’s Cancer Institute (Queen Mary University of London), during which time Laura completed a 3-month internship with Cancer Research UK’s Commercial Partnerships Team (now part of Cancer Research Horizons).
Prior to joining as a Business Manager, Laura completed LifeArc’s Technology Transfer Fellowship programme, gaining operational experience at four of London’s leading technology transfer offices: Imperial Innovations, Queen Mary Innovation, LifeArc and UCL Business. Now, as a Senior Business Manager, she remains engaged with LifeArc’s Fellowship programmes, providing mentoring and support to new cohorts of Fellows.
